MDL Sought For Generic Drug Valsartan Over Concerns Of Possible Carcinogen

Mealey's (October 31, 2018, 12:19 PM EDT) -- WASHINGTON, D.C. — A plaintiff on Oct. 22 asked the Judicial Panel on Multidistrict Litigation (JPMDL) to centralize 11 federal valsartan product liability cases before Judge Freda L. Wolfson of the U.S. District Court for the District of New Jersey (In Re: Valsartan N-Nitrosodimethylamine [NDMA] Contamination Products Liability Litigation, MDL Docket No. 2875, JPMDL)....

Attached Documents

Related Sections